S
SPRO
Spero Therapeuti
2.670
-0.110-3.96%After Hours: 2.730 +0.060 +2.25%19:28 04/10 EDT
OPEN/PREV CLOSE2.800/2.780
TODAY RANGE2.625-2.800
VOL786.98K
MARKET CAP154.57M
52 WEEK RANGE0.5052-3.220
AVG VOL (3M)337.63K
% TURNOVER1.36%
TURNOVER--
P/E (TTM)18.39
% RANGE6.30%
EPS(TTM)0.1452
P/E(FORWARD)3.985
P/B2.552
BVPS1.046
DIVIDEND--
P/S2.255
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP119.69M
SHARES OUTSTANDING57.89M
NEXT EARNINGS05/11-05/15
FREE FLOAT44.83M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·03/28 00:26
Spero Therapeutics (SPRO) Earnings Turn Positive Challenging Bearish Profitability Narratives
Reuters·03/26 20:22
Spero Therapeutics Q4 revenue nearly triples, swings to profit
Reuters·03/26 20:22
CORRECTED-Spero Therapeutics Q4 revenue nearly triples, swings to profit
Seeking Alpha·03/26 20:09
Spero Therapeutics Non-GAAP EPS of $0.53, revenue of $41.3M
Dow Jones·03/26 20:05
*Spero Therapeutics 4Q Net $31.5M >SPRO
Dow Jones·03/26 20:05
*Spero Therapeutics 4Q EPS 53c >SPRO
Dow Jones·03/26 19:31
U.S. Earnings Preview: After Market Close March 26
Seeking Alpha·03/26 14:00
Here are the major earnings after the close Thursday
Benzinga·03/26 11:11
Earnings Scheduled For March 26, 2026
Reuters·03/18 20:07
Spero Therapeutics to report Q4 and full-year 2025 financial results
Simply Wall St·02/14 12:29
Trade Alert: CEO, CFO Of Spero Therapeutics Esther Rajavelu Has Sold Stock